| Code | Description | Claims | Beneficiaries | Total Paid |
| 99215 |
Prolong outpt/office vis |
2,633 |
1,887 |
$116K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,397 |
893 |
$105K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,611 |
2,337 |
$81K |
| 96367 |
|
1,970 |
581 |
$56K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,055 |
435 |
$19K |
| 80053 |
Comprehensive metabolic panel |
1,249 |
951 |
$13K |
| 85027 |
|
1,852 |
1,301 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
241 |
227 |
$6K |
| 85007 |
|
1,806 |
1,294 |
$6K |
| 83735 |
|
790 |
595 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
130 |
62 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
267 |
241 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,042 |
719 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
117 |
78 |
$655.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
687 |
246 |
$628.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
299 |
120 |
$280.65 |
| J3490 |
Unclassified drugs |
78 |
26 |
$26.04 |